Medicare to Negotiate with Pharmaceutical Industry
In March 2015, Health Attitude: Unraveling and Solving the Complexities of Healthcare was published. One of the recommendations made in the book, to address the spiraling healthcare cost for Americans, was to allow Medicare to negotiate the price of drugs. It was a lone voice at the time, but since then more and more people, including the […]
AI and Congress
On April 10th and 11th, 2018, Facebook CEO Mark Zuckerberg was questioned for almost 10 hours by senators and representatives before joint Senate Judiciary and Commerce Committees regarding the company’s privacy policies and use of data collected on the company’s social media web site. The most used phrase in Mr. Zuckerberg’s responses was AI (artificial […]
Disrupting Healthcare
The State of the Union topics about tax reform, jobs, immigration, and infrastructure are all important, but what about healthcare? Healthcare represents nearly 20% of our economy, people are going bankrupt or dying because of the cost of drugs, basic healthcare is unaffordable for millions, and we are the only developed country in the world […]
Drug Makers Putting Profit Before The Elderly
The Medpage Today staff reported this week on a CNN investigation of Nuedexta, a drug approved for PseudoBulbar Affect (PBA). The investigation found PBA is being marketed aggressively to the elderly as a therapy for dementia. Even though independent studies indicate PBA is only rarely associated with dementia, Avanir, the drug’s manufacturer, has spent millions of dollars promoting […]
Healthcare Cost
Healthcare cost is extraordinarily high in America. We spend 50-100% more per person than other developed countries. It is not because their care is better, to the contrary. Our cost is high for a number of reasons which I discussed in some detail in Health Attitude: Unraveling and Solving the Complexities of Healthcare. The media and […]
